USP6NL Knockout Hela Cell Line

Product Type:
In Stock Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Uterus (cervix)
Disease:
Adenocarcinoma
Host Cell:
HeLa
Gene Name:
USP6NL
Inquire Now
✓ In stock
🚚 Ships next business day
Ask a Question

USP6NL Knockout Hela Cell Line provides a loss-of-function model for USP6NL, a GTPase-activating protein that inactivates RAB5 and RAB21 to regulate early endosome fusion and receptor recycling. Derived from HPV-18 positive Hela cells, it is ideal for investigating endocytic trafficking and signaling in a cervical adenocarcinoma context. Key applications include dissecting EGFR and integrin trafficking, autophagy, and drug resistance using transferrin uptake, receptor recycling, co-immunoprecipitation, and migration assays. The model enables study of USP6NL interactions with FIP2 and EHD1 in cell proliferation control.

Shipping Info: Cryopreserved in vials and shipped on dry ice

Disclaimer: For Research Use Only
Host CellHeLa
Sex of DonorFemale
Age31 years
Gene NameUSP6NL
Gene IdentifierNCBI Gene ID 9712
MorphologyEpithelial-like
Growth ModeAdherent
StorageLiquid nitrogen (LN2)
Temperature37°C
Atmosphere5% CO₂
Sterility testingThe bacterial, yeast, and fungi are not detected in these cells by daily monitor.
Mycoplasma testingNegative for mycoplasma through PCR analysis

Intended Use: This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

Disclaimer: Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.

By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use.

This product is provided "AS IS". For Research Use Only. Not for human or animal therapeutic use.

Description

The USP6NL Knockout Hela Cell Line is a CRISPR/Cas9-edited knockout cell line designed for loss-of-function studies of USP6NL. This genetically defined model eliminates endogenous USP6NL expression, enabling precise investigation of its role in endocytic trafficking and signaling. Created in the well-characterized Hela background, the cell line provides a stable and reliable system for dissecting USP6NL-dependent mechanisms without interference from residual protein activity.

The parental Hela cell line originates from a cervical adenocarcinoma and is immortalized, HPV-18 positive, and highly proliferative with an aneuploid karyotype. These epithelial cells are widely utilized in cancer research due to their robust growth kinetics and ease of genetic manipulation. Their rapid division and well-documented signaling pathways make Hela cells an ideal host for knockout models, ensuring reproducibility and scalability in functional analyses.

USP6NL encodes a GTPase-activating protein (GAP) that specifically inactivates RAB5 and RAB21, master regulators of early endosome dynamics. By catalyzing GTP hydrolysis on RAB5, USP6NL promotes the conversion to inactive RAB5-GDP, thereby modulating endosome fusion, maturation, and cargo sorting. Its activity is stimulated by upstream signals such as EGF receptor activation and involves interactions with RAB5, RAB21, FIP2, and EHD1. Downstream, USP6NL controls EGFR recycling, integrin trafficking, and autophagic flux, positioning this GAP as a critical node linking endocytic regulation to cell proliferation and migration.

In the Hela cell context, USP6NL knockout disrupts the balance of endosomal trafficking, leading to altered receptor recycling and signal transduction. Given the cervical adenocarcinoma origin and HPV-18 driven dysregulated growth signaling, this model is highly pertinent for investigating how endocytic perturbations contribute to cancer phenotypes, including drug resistance. The altered trafficking dynamics may also provide insights into viral manipulation of host endocytic pathways.

This knockout cell line supports diverse experimental approaches, including quantitative transferrin uptake and receptor recycling assays to monitor endocytic kinetics, co-immunoprecipitation and immunofluorescence to map protein interactions, and flow cytometry for surface receptor levels. Migration assays enable functional evaluation of cell motility. Researchers can leverage this tool to dissect EGF receptor signaling, integrin trafficking, and autophagy. For further details, please contact Ascent Research.